Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 6

Results: 20

Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1497, doi. 10.1007/s00262-021-03098-w
By:
- Sun, Mengmeng;
- Zeng, Han;
- Jin, Kaifeng;
- Liu, Zhaopei;
- Hu, Baoying;
- Liu, Chunnan;
- Yan, Sen;
- Yu, Yanze;
- You, Runze;
- Zhang, Hongyi;
- Chang, Yuan;
- Liu, Li;
- Zhu, Yu;
- Xu, Jiejie;
- Xu, Le;
- Wang, Zewei
Publication type:
Article
Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1545, doi. 10.1007/s00262-021-03094-0
By:
- Conteduca, V.;
- Medri, M.;
- Mazzoni, L.;
- De Giorgi, U.;
- Stanganelli, I.
Publication type:
Article
Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1431, doi. 10.1007/s00262-021-03093-1
By:
- Qin, Meng;
- Hamanishi, Junzo;
- Ukita, Masayo;
- Yamanoi, Koji;
- Takamatsu, Shiro;
- Abiko, Kaoru;
- Murakami, Ryusuke;
- Miyamoto, Taito;
- Suzuki, Haruka;
- Ueda, Akihiko;
- Hosoe, Yuko;
- Horie, Akihito;
- Yamaguchi, Ken;
- Mandai, Masaki
Publication type:
Article
Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1519, doi. 10.1007/s00262-021-03092-2
By:
- Li, Hui;
- Wu, Miaofang;
- Wu, Zhuna;
- Liang, Jinxiao;
- Wang, Lijuan;
- Yang, Xi;
- Lin, Zhongqiu;
- Li, Jing
Publication type:
Article
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1393, doi. 10.1007/s00262-021-03091-3
By:
- Yang, Jin-Ji;
- Huang, Cheng;
- Fan, Yun;
- Pan, Hongming;
- Feng, Jifeng;
- Jiang, Liyan;
- Li, Xing-Ya;
- Liu, Xiao-Qing;
- Xiong, Jian-Ping;
- Zhao, Yan-Qiu;
- Cheng, Ying;
- Ma, Rui;
- Wang, Jie;
- Wang, Yina;
- Liu, Yan-Hui;
- Lin, Dong-Mei;
- Wang, Tao;
- Shi, Wei;
- Zou, Jianjun;
- Wu, Yi-Long
Publication type:
Article
Clinical determinants of long-term survival in metastatic uveal melanoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1467, doi. 10.1007/s00262-021-03090-4
By:
- Koch, Elias A. T.;
- Petzold, Anne;
- Wessely, Anja;
- Dippel, Edgar;
- Erdmann, Michael;
- Heinzerling, Lucie;
- Hohberger, Bettina;
- Knorr, Harald;
- Leiter, Ulrike;
- Meier, Friedegund;
- Mohr, Peter;
- Rahimi, Farnaz;
- Schell, Beatrice;
- Schlaak, Max;
- Terheyden, Patrick;
- Schuler-Thurner, Beatrice;
- Ugurel, Selma;
- Utikal, Jochen;
- Vera, Julio;
- Weichenthal, Michael
Publication type:
Article
First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1345, doi. 10.1007/s00262-021-03089-x
By:
- He, Mingfeng;
- Zheng, Taihao;
- Zhang, Xiaoyue;
- Peng, Yuan;
- Jiang, Xuan;
- Huang, Yusheng;
- Tan, Benxu;
- Yang, Zhenzhou
Publication type:
Article
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1453, doi. 10.1007/s00262-021-03087-z
By:
- Núñez, Kelley G.;
- Sandow, Tyler;
- Fort, Daniel;
- Hibino, Mina;
- Wright, Paige;
- Cohen, Ari J.;
- Thevenot, Paul T.
Publication type:
Article
Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1331, doi. 10.1007/s00262-021-03085-1
By:
- Pan, Cheng;
- Fujiwara, Yukio;
- Horlad, Hasita;
- Iriki, Toyohisa;
- Shiraishi, Daisuke;
- Komohara, Yoshihiro
Publication type:
Article
Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1479, doi. 10.1007/s00262-021-03084-2
By:
- Ravirala, Divya;
- Pei, Guangsheng;
- Zhao, Zhongming;
- Zhang, Xiaoliu
Publication type:
Article
Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1443, doi. 10.1007/s00262-021-03083-3
By:
- Yang, Kaili;
- Han, Lu;
- Wu, Shikai;
- Qu, Xiujuan;
- Li, Qin;
- Zhao, Chuanhua;
- Zhou, Jing;
- Jin, Xuan;
- Wang, Yusheng;
- Yan, Dong;
- Cheng, Zhiqiang;
- Hua, Yuwei;
- Zhang, Yan;
- Ge, Yang;
- Sun, Jinghua;
- Deng, Wei;
- Zhao, Lin;
- Zhao, Yunbo
Publication type:
Article
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1357, doi. 10.1007/s00262-021-03078-0
By:
- Takahashi, Miho;
- Watanabe, Satoshi;
- Suzuki, Ryo;
- Arita, Masashi;
- Sato, Ko;
- Sato, Miyuki;
- Sekiya, Yuki;
- Abe, Yuko;
- Fujisaki, Toshiya;
- Ohtsubo, Aya;
- Shoji, Satoshi;
- Nozaki, Koichiro;
- Ichikawa, Kosuke;
- Kondo, Rie;
- Saida, Yu;
- Hokari, Satoshi;
- Aoki, Nobumasa;
- Hayashi, Masachika;
- Ohshima, Yasuyoshi;
- Koya, Toshiyuki
Publication type:
Article
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1403, doi. 10.1007/s00262-021-03077-1
By:
- Jiao, Defeng;
- Zheng, Xiaohu;
- Du, Xianghui;
- Wang, Dong;
- Hu, Ziming;
- Sun, Rui;
- Tian, Zhigang;
- Fu, Binqing;
- Wei, Haiming
Publication type:
Article
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1313, doi. 10.1007/s00262-021-03076-2
By:
- Guo, Jun-Nan;
- Chen, Du;
- Deng, Shen-Hui;
- Huang, Jia-Rong;
- Song, Jin-Xuan;
- Li, Xiang-Yu;
- Cui, Bin-Bin;
- Liu, Yan-Long
Publication type:
Article
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1531, doi. 10.1007/s00262-021-03075-3
By:
- Nickles, Emily;
- Dharmadhikari, Bhushan;
- Yating, Li;
- Walsh, Robert J.;
- Koh, Liang Piu;
- Poon, Michelle;
- Tan, Lip Kun;
- Wang, Ling-Zhi;
- Ang, Yvonne;
- Asokumaran, Yugarajah;
- Chong, Wan Qin;
- Huang, Yiqing;
- Loh, Kwok Seng;
- Tay, Joshua;
- Soo, Ross;
- Koh, Mickey;
- Ho, Liam Pock;
- Chan, Marieta;
- Niam, Madelaine;
- Soh, Melissa
Publication type:
Article
Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1419, doi. 10.1007/s00262-021-03074-4
By:
- Kiguchi, Toru;
- Yamaguchi, Masaki;
- Takezako, Naoki;
- Miyawaki, Shuichi;
- Masui, Koichi;
- Ihara, Yuichiro;
- Hirota, Masao;
- Shimofurutani, Naoko;
- Naoe, Tomoki
Publication type:
Article
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1281, doi. 10.1007/s00262-021-03073-5
By:
- Shalaby, Nourhan;
- Dubois, Veronica Phyllis;
- Ronald, John
Publication type:
Article
Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1295, doi. 10.1007/s00262-021-03069-1
By:
- Cao, Kui;
- Liu, Mingdong;
- Ma, Keru;
- Jiang, Xiangyu;
- Ma, Jianqun;
- Zhu, Jinhong
Publication type:
Article
Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1507, doi. 10.1007/s00262-021-03063-7
By:
- Wang, Bo;
- He, Zhihua;
- Yu, Hao;
- Ou, Ziwei;
- Chen, Junyu;
- Yang, Meihua;
- Fan, Xinxiang;
- Lin, Tianxin;
- Huang, Jian
Publication type:
Article
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1371, doi. 10.1007/s00262-021-03057-5
By:
- Sidorov, Semjon;
- Fux, Lara;
- Steiner, Katja;
- Bounlom, Samyo;
- Traxel, Sabrina;
- Azzi, Tarik;
- Berisha, Arbeneshe;
- Berger, Christoph;
- Bernasconi, Michele;
- Niggli, Felix K.;
- Perner, Yvonne;
- Pather, Sugeshnee;
- Kempf, Werner;
- Nadal, David;
- Bürgler, Simone
Publication type:
Article